MangoRx vs Strut Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: MangoRx scores higher on our rubric, 7.5/10 against 6.2/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit MangoRx - our pick of these two →or find your match

MangoRx beats Strut Health overall, scoring 7.5/10 vs 6.2/10. Published pricing is not a like-for-like monthly comparison: MangoRx is from $299/mo; Strut Health is from $99/mo. Choose MangoRx for needle-phobic users who want oral-only glp-1 tablets from a publicly traded company. Choose Strut Health for users who prefer a needle-free oral semaglutide option at a reasonable price.

A side-by-side look at MangoRx and Strut Health to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

MangoRx

#22 of 54

7.5/10

Multi-service telehealth platform offering compounded GLP-1 alongside other health services.

Visit MangoRx

Strut Health

#43 of 54

6.2/10

Oral-focused GLP-1 provider offering needle-free semaglutide options for users who prefer pills over injections.

Visit Strut Health

Feature	MangoRx	Strut Health
Why each one	Oral dissolving tablets exclusively (zero injections) from a publicly traded company (NASDAQ: MGRX) with SEC-level financial transparency.	Needle-free first: oral compounded semaglutide from $99/mo, one of the lowest oral entry prices anywhere, with oral tirzepatide and auto-refill injectables on the same platform if you switch.
Our Score	7.5/10	6.2/10
Headline Price	from $299/mo	from $99/mo
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	Needle-phobic users who want oral-only GLP-1 tablets from a publicly traded company	Users who prefer a needle-free oral semaglutide option at a reasonable price
Watch out for	Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you.	Compounded only, no brand-name Wegovy or Zepbound. Strut does not publish formulation-specific pharmacokinetic or comparative outcome evidence for its oral tablets, so their absorption and weight-loss results versus approved injections are unknown.
Ranking	#22	#43
Get started	Visit MangoRx	Visit Strut Health

Pros & Cons Compared

MangoRx

Pros

+Oral dissolving tablets exclusively, zero injections for any GLP-1 option
+Publicly traded on NASDAQ (MGRX), SEC-required financial transparency that private competitors can't match
+Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
+Free 100% online consultation with no video call required

Cons

−Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you.
−Early-stage public company with limited revenue; the same SEC filings that provide transparency also show the financial uncertainty reflected in the stock.
−Oral tablets are the only format, with no injectable option if you want higher bioavailability. If you may switch to injections later, pick a platform that carries both.

Strut Health

Pros

+Specializes in oral compounded semaglutide, the go-to for patients who absolutely won't do injections
+Needle-free oral semaglutide tablets from $99/mo, one of the lowest oral entry prices in the table, with oral tirzepatide ($199/mo) and auto-refill injectables ($149 to $199/mo) if you switch formats
+Clear educational content about oral semaglutide absorption and how to maximize effectiveness
+Simple enrollment: online questionnaire, async provider review, medication shipped to your door

Cons

−Compounded only, no brand-name Wegovy or Zepbound. Strut does not publish formulation-specific pharmacokinetic or comparative outcome evidence for its oral tablets, so their absorption and weight-loss results versus approved injections are unknown.
−Compounded oral semaglutide is not FDA-approved as a finished product or established as bioequivalent to approved oral or injectable semaglutide; do not infer equivalent dosing or results

Our Verdict

MangoRx edges out Strut Health with a score of 7.5/10 vs 6.2/10. Published pricing is not a like-for-like monthly comparison: MangoRx is from $299/mo; Strut Health is from $99/mo.